Clinical trial
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults 18-64 Years of Age
NCT02768805 is registered in ClinicalTrials.gov with Medicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Adults 18-64 Years of Age
- Lead sponsor
- Medicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 2, 2016
- Completion date
- November 26, 2016
- Enrollment
- 900 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.